These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3574745)

  • 1. [Treatment of lymph node metastasis in ovarian cancer].
    Tolino A; Di Serio C; Borruto Caracciolo G; Bartiromo F; Cinque SM
    Minerva Ginecol; 1987; 39(1-2):31-6. PubMed ID: 3574745
    [No Abstract]   [Full Text] [Related]  

  • 2. Ovarian cancer patients with "node-positive-only" Stage IIIC disease have a more favorable outcome than Stage IIIA/B.
    Ferrandina G; Scambia G; Legge F; Petrillo M; Salutari V
    Gynecol Oncol; 2007 Oct; 107(1):154-6. PubMed ID: 17614126
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of ovarian cancer with pelvic and paraaortic lymph node metastasis].
    Ebina Y; Yamamoto R; Sakuragi N
    Nihon Rinsho; 2004 Oct; 62 Suppl 10():565-9. PubMed ID: 15535309
    [No Abstract]   [Full Text] [Related]  

  • 4. [Status of lymph node excision in surgical treatment of ovarian cancer].
    Lahousen M; Stettner H; Pickel H
    Gynakol Rundsch; 1990; 30 Suppl 1():30-3. PubMed ID: 2079294
    [No Abstract]   [Full Text] [Related]  

  • 5. Significance of preoperative serum CA-125 levels in the prediction of lymph node metastasis in epithelial ovarian cancer.
    Kim HS; Park NH; Chung HH; Kim JW; Song YS; Kang SB
    Acta Obstet Gynecol Scand; 2008; 87(11):1136-42. PubMed ID: 18951217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
    Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A rational treatment of stage I epithelial ovarian cancer].
    Wang W; Huo R
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jul; 31(7):387-9. PubMed ID: 9275407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0).
    Sakuragi N; Yamada H; Oikawa M; Okuyama K; Fujino T; Sagawa T; Fujimoto S
    Gynecol Oncol; 2000 Nov; 79(2):251-5. PubMed ID: 11063653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Principles of staging laparotomy in ovarian cancer].
    Sevin BU; Graeff H
    Chirurg; 1994 Jan; 65(1):2-9. PubMed ID: 8149795
    [No Abstract]   [Full Text] [Related]  

  • 11. Axillary lymph node metastasis from serous ovarian cancer: a case report and review of the literature.
    Aydin C; Unalp HR; Baloğlu A; Inci AG; Yiğit S; Yavuzcan A
    Arch Gynecol Obstet; 2009 Feb; 279(2):203-7. PubMed ID: 18470522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer.
    Camara O; Sehouli J
    Anticancer Res; 2009 Jul; 29(7):2837-43. PubMed ID: 19596971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contralateral pelvic and aortic lymph node metastasis in clinical stage I epithelial ovarian cancer.
    Walter AJ; Magrina JF
    Gynecol Oncol; 1999 Jul; 74(1):128-9. PubMed ID: 10385564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
    Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
    Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic pelvic and paraaortic lymphadenectomy for advanced ovarian cancer--therapeutic advance or surgical folly?
    Hacker NF
    Gynecol Oncol; 1995 Mar; 56(3):325-7. PubMed ID: 7705664
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
    Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
    Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinically important aspects of lymph node assessment in colon cancer.
    Wright FC; Law CH; Berry S; Smith AJ
    J Surg Oncol; 2009 Mar; 99(4):248-55. PubMed ID: 19235179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer.
    Aletti GD; Dowdy S; Podratz KC; Cliby WA
    Am J Obstet Gynecol; 2006 Dec; 195(6):1862-8. PubMed ID: 17132488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous regression in recurrent epithelial ovarian cancer.
    Fujiwaki R; Sawada K
    Arch Gynecol Obstet; 2007 May; 275(5):389-91. PubMed ID: 17177031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The place of lumo-aortic and pelvic lymph node dissection in the treatment of ovarian cancer].
    Salet-Lizée D; Alsary S
    J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S45-12S49. PubMed ID: 19194358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.